COMP report to the Commission in relation to article 10 of Regulation 141/2000 on orphan medical products

Author (Corporate)
Publisher
Publication Date 05/08/2005
Content Type

The European Medicines Agency's Committee on Orphan Medicinal Products (COMP), on 5 August 2005, published a report on its experience to date with the EU legislation on orphan medicinal products adopted in April 2000. The report highlights the success of the legislation - in particular the public health benefits that have resulted for patients suffering from rare diseases - while also identifying areas where the EU policy on orphan medicines could be strengthened. Please click on the first Related Url for the Annexes to this report.
Source Link Link to Main Source http://www.emea.europa.eu/pdfs/human/comp/3521805en.pdf
Related Links
European Medicines Agency: COMP: General reporting http://www.emea.europa.eu/htms/human/comp/compgen.htm
European Medicines Agency: Orphan medicinal product designation in the European Union: Leaflet, 2003 http://www.emea.europa.eu/pdfs/human/comp/leaflet/661801En.pdf
Subject Categories
Countries / Regions